NeoGenomics
NEO
$12.31
Share price
-0.40%
Change (1 day)
23.10%
Change (1 year)
NeoGenomics (NEO) - Cash on Hand
Cash on Hand as of June 2023 : $0.40 B
According to NeoGenomics
's latest financial reports the company has $0.40 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
NeoGenomics - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.43 B | -15.02% |
| 2021-12-31 | $0.51 B | 73.97% |
| 2020-12-31 | $0.29 B | 71.23% |
| 2019-12-31 | $0.17 B | 1663.49% |
| 2018-12-31 | $9.81 M | -23.48% |
| 2017-12-31 | $12.82 M | 2.36% |
| 2016-12-31 | $12.52 M | -46.52% |
| 2015-12-31 | $23.42 M | -30.48% |
| 2014-12-31 | $33.68 M | 596.92% |
| 2013-12-31 | $4.83 M | 158.78% |
| 2012-12-31 | $1.86 M | -28.92% |
| 2011-12-31 | $2.62 M | 139.56% |
| 2010-12-31 | $1.09 M | -32.74% |
| 2009-12-31 | $1.63 M | 248.39% |
| 2008-12-31 | $0.46 M | 122.33% |
| 2007-12-31 | $0.21 M | 66.77% |
| 2006-12-31 | $0.12 M | 1053.75% |
| 2005-12-31 | $0.01 M | -90.28% |
| 2004-12-31 | $0.11 M | 349.28% |
| 2003-12-31 | $0.02 M | |
| 2001-12-31 | $0.07 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Quest Diagnostics
DGX | $0.12 B | -69.22% | 🇺🇸 USA |
 LabCorp LH | $1.93 B | 371.63% | 🇺🇸 USA |
 RadNet RDNT | $0.35 B | -12.87% | 🇺🇸 USA |
 Psychemedics PMD | $2.44 M | -99.40% | 🇺🇸 USA |
 Enzo Biochem ENZ | $2.63 M | -99.36% | 🇺🇸 USA |